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CD200This study tested the hypothesis that a set of predominantly myeloid restricted receptors (F4/80, CD36,
Dectin-1, CD200 receptor and mannan binding lectins) and the broadly expressed CD200 played a role in a
key function of plasmacytoid DC (pDC), virally induced type I interferon (IFN) production. The Dectin-1
ligands zymosan, glucan phosphate and the anti-Dectin-1 monoclonal antibody (mAb) 2A11 had no effect on
inﬂuenza virus induced IFNα/β production by murine splenic pDC. However, mannan, a broad blocking
reagent against mannose speciﬁc receptors, inhibited IFNα/β production by pDC in response to inactivated
inﬂuenza virus. Moreover, viral glycoproteins (inﬂuenza virus haemagglutinin and HIV-1 gp120) stimulated
IFNα/β production by splenocytes in a mannan-inhibitable manner, implicating the function of a lectin in
glycoprotein induced IFN production. Lastly, the effect of CD200 on IFN induction was investigated. CD200
knock-out macrophages produced more IFNα than wild-type macrophages in response to polyI:C, a MyD88-
independent stimulus, consistent with CD200's known inhibitory effect on myeloid cells. In contrast, blocking
CD200 with an anti-CD200 mAb resulted in reduced IFNα production by pDC-containing splenocytes in
response to CpG and inﬂuenza virus (MyD88-dependent stimuli). This suggests there could be a differential
effect of CD200 onMyD88 dependent and independent IFN induction pathways in pDC andmacrophages. This
study supports the hypothesis that a mannan-inhibitable lectin and CD200 are involved in virally induced
type I IFN induction.itute, Department of Biochem-
d, OX1 3QU, UK. Tel.: +44
iller).
 license.© 2011 Elsevier B.V. Open access under CC BY license.1. Introduction
Plasmacytoid dendritic cells (pDC), in contrast to conventional
dendritic cells, are a rare leukocyte population which can rapidly
secrete large amounts of type I IFN (IFNα/β) in response to viruses,
including inﬂuenza virus, and some Toll-like receptor (TLR) ligands,
e.g. CpG oligodeoxynucleotide (ODN) [1]. Although the original
identiﬁcation of pDC was complicated by their apparent lack of
expression of surface markers associated with lymphoid and myeloid
lineages e.g. CD19, CD3, CD11b, CD11c (in humans), CD13, CD33 and
CD14 [2], pDC have subsequently been found to possess both
lymphoid and myeloid characteristics. Murine pDC are CD11c+B220
+CD11b−Ly6C+ cells [1], and can also be deﬁned using single mAbs,
for example 120G8 [3] and anti-Siglec-H [4,5].
Innate immune cells express many pattern recognition receptors
(PRR) that allow sensing of foreign moieties, such as TLR, C-type
lectins, scavenger receptors, retinoic acid inducible gene (RIG)-I-like
andNod-like receptors. Generally, these recognizemicrobe-associatedmolecular patterns (MAMP) that are not present on host molecules,
allowing discrimination between self and non-self. As viruses replicate
in host cells they are composed of nucleic acids, lipids and
glycoproteins derived from self molecules which makes the mecha-
nisms of viral detectionmore subtle. pDCs detect viruses through TLR7
and TLR9 recognition of viral genomes (e.g. single stranded RNA and
CpG containing DNA). However, viruses contain additional potential
MAMP, such as glycoproteins, which may be distinguished from self
through the virally encoded amino acid composition of the glycopro-
teins or host derived modiﬁcations. For example viral glycoproteins
are presented in a repetitive array on the virus particle, the
glycosylationmay differ due to the cellular stress during viral infection
and the properties of the glycoproteins themselves may lend
themselves to different glycosylation patterns compared to host
proteins. Several TLR, C-type lectins (e.g. mannose receptor, DC-
SIGN, DC-SIGNR and SIGNR1), scavenger receptors and collectins bind
to glycoproteins from a range of DNA and RNA viruses (reviewed in
[6]). Therefore, we investigated whether the PRR on pDC were
involved in viral particle and glycoprotein recognition leading to
type I IFN production.
Immune cells also express immuno-modulatory receptors. Several
mechanisms dampen IFNα/β production, for example, deubiquitinat-
ing enzyme A (DUBA) is a negative regulator of IFNα/β downstream
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(CD200R) are an immunomodulatory receptor–ligand pair which
negatively regulate a range of myeloid cell functions, including
proinﬂammatory cytokine secretion in response to lipopolysaccharide
(LPS) stimulation [8]. We therefore tested whether CD200 and
CD200R affected different pathways of IFNα induction.
2. Materials and methods
2.1. Mice
Cells were isolated from the 129/SvEv mouse strain unless stated
otherwise. In addition, cells were prepared from CD200 knock-out
(KO) [9] and C57BL/6J strains. All animals were kept and handled in
accordance with institutional guidelines.
2.2. Preparation of primary cells
Single cell suspensions of splenocytes and bone marrow-derived
macrophages were isolated and prepared as described previously
[10–12].
2.3. Spleen cell and macrophage stimulation
Spleen cells or bone marrow-derived macrophages were stimu-
lated in 96, 24 or 6 well tissue culture plates for 6–24 h with
inactivated inﬂuenza virus, soluble glycoproteins or TLR agonists
under the speciﬁc conditions indicated in each ﬁgure. Spleen cells
were at 2.7×107 cells/ml and macrophages at 1×106 cells/ml unless
otherwise stated. Where the IFN in samples was measured by
enzyme-linked immunoabsorbent assay (ELISA) or bioassay, super-
natants were collected and stored at −20 °C before analysis. Where
IFNα/β production was measured by intracellular staining, after 5 h
1 μl GolgiPlug (GE Healthcare, Amersham, Buckinghamshire, UK) was
added perml of media and the incubation continued. At the end of the
stimulation cells were detached from the plate by scraping, washed
three times in phosphate buffered saline (PBS), ﬁxed in 1%
formaldehyde and stained with mAb to measure IFNα/β production
by intracellular staining.
2.4. Stimuli
β-propiolactone inactivated inﬂuenza virus (A/Guangdong/25/93)
(H3N2), grown in embryonated hens' eggs and subsequently puriﬁed,
was provided byM. Hocart. This virus is referred to here as inactivated
inﬂuenza virus andwasnon infectious (b100plaque formingunits/ml)
byplaque assay (data not shown). Insect expressed glycoproteinswere
puriﬁed from the supernatant of baculovirus infected Spodoptera
frugiperda (Sf9) insect cells. H5 haemagglutinin (HA) is from an H5N1
inﬂuenzavirus (A/Vietnam/1194/04). H1HA is fromH1 inﬂuenza virus
(A/New York/04). Thesewere expressedwith a human IgG1 Fc tag and
puriﬁed as described previously [13]. The soluble outer domain
(residues 251–481) of gp120 from HIV-1CN54 was fused to a human
IgG1 Fc tag. Alternatively, the gp120CN54 was fused to a human IgG1 Fc
tag mutated at leucine 234 and leucine 235 to valine and alanine
respectively to prevent Fc receptor binding and is referred to here as
gp120CN54(VA) [14,15]. The spike protein from the Hong Kong isolate
of severe acute respiratory syndrome (SARS) coronavirus was
expressed with a tandem afﬁnity puriﬁcation (TAP) tag [16]. For
depletion of Fc tagged proteins, 80 μl of GammaBind Plus Sepharose
were washed three times in PBS, pelleted and resuspended in 200 μl
volume of 10 μg/ml of H1 HA, H5 HA or gp120CN54 diluted in PBS. The
GammaBind Plus Sepharose was incubated with the samples for 23 h,
rotating at 4 °C and then pelleted by centrifugation. To assess the
effectiveness of the depletion, these samples were separated on a 10%
gel by SDS-PAGE and proteins were detected by silver staining usingstandard protocols. The beads were enriched for protein (data not
shown), while the supernatants were depleted of protein (assessed by
silver staining in Fig. 1E). As a control, the same volume and
concentrations of proteins were incubated with PBS alone for 23 h.
The “depleted” supernatants or mock treated protein samples were
used in subsequent experiments. The synthetic agonists polyI:C (GE
healthcare) and CpGODN2216 (Invivogen, San Diego, California, USA)
were also used in stimulations.
2.5. Blocking experiments
2.7×107 spleen cells/ml (unless stated otherwise in ﬁgure legend)
were pre-incubated in 0.75 ml RPMI with serum for 30 min at 37 °C
without any additional factors, or with the following (at concentrations
indicated in the ﬁgure legends, evidence for blocking function of
antibody/compound referenced where relevant): F4/80 [17], anti-
Dectin-1 (2A11) [18], anti-CD36 (MF3) [19], anti-CD200 (OX90), anti-
CD200R (OX110), rat IgG1 (Serotec, Kidlington, Oxfordshire, UK), rat
IgG2a (Serotec) or rat IgG2b (Serotec) mAb, maleylated-bovine serum
albumin (BSA) (gift from C. Neyen, University of Oxford, UK), BSA
(Sigma-Aldrich, Gillingham, Dorset, UK), fucoidan (Sigma-Aldrich) [20],
laminarin (from Laminaria digitata) (Sigma-Aldrich), glucan phosphate
(from Saccharomyces cerevisiae) (gift from D. Williams, East Tennessee
State University, USA) [18,21] or mannan (from Saccharomyces
cerevisiae) (Sigma-Aldrich). Cells were then stimulated with media
alone, 200 or 530 haemagglutinating units (HAU)/ml inactivated
inﬂuenza virus, 1 μM CpG ODN 2216, 1.3 μg/ml H1 HA, or 0.13 μg/ml
gp120CN54(VA), with the blocking reagent still present, as described in
the relevant ﬁgure legends.
2.6. Intracellular cytokine staining for IFNα and IFNβ production by
pDCs
Cells were ﬁrst ﬁxed in 1% formaldehyde and then 0.2% saponin
(Sigma-Aldrich) was included in all subsequent blocking, staining and
wash steps. Following ﬁxation, Fc receptors were blocked with FACS
wash (0.5% BSA, (Sigma-Aldrich), 5 mM EDTA, 2 mM NaN3 in PBS)
supplemented with 5% rabbit serum (Invitrogen) and 4 μg/ml 2.4G2
anti-CD32/CD16 mAb [22]. Spleen cells were stained with 120G8 [3],
to identify pDC, and with mAb to measure IFNα and IFNβ production
(clones 4EA1 and 7FD3 respectively [23]), as described elsewhere
[12].
2.7. FACS analysis
Data were acquired on the FACSCalibur system (Becton Dickenson,
Oxford, UK) and analyzed using FlowJo software (Tree Star Incorpo-
rated, Ashland, Oregon, USA). To calculate the percentage of IFNα+ or
IFNβ+ pDCs, debris was gated out by forward and side scatter
characteristics and 120G8+ cells were selected by comparison to
control staining. A gate was set where typically 5 or 10% of pDCs
(120G8+ cells) fell within the IFNα+ or IFNβ+ gates from a sample of
spleen cells stimulated with media alone. This gate was applied to all
other samples to measure the percentage of IFNα+ or IFNβ+ pDCs
following stimulation.
2.8. IFNα ELISA
The IFNα ELISA used is described elsewhere [12] Brieﬂy, plates
were coated with anti-IFNα mAb (clone 4EA1) overnight and then
samples were added for 2 h. IFNα was detected with a rabbit
polyclonal Ab against IFNα and an alkaline phosphase conjugated
secondary and absorbance at 405 nm was recorded. To estimate the
amount of IFNα in the samples, the mean absorbance for duplicate
samples was compared to that from a standard curve of the IFNαA.
Fig. 1.Glycoproteins stimulate IFNproduction in amannan-inhibitablemanner. Spleen cellswerepre-incubatedwithmedia alone (white bars) orwith (A) 5 mg/ml or (B) 0.1–5 mg/ml
mannan (black bars). Cells were then stimulated with 200 HAU/ml inactivated inﬂuenza virus or in media for 6 h. IFNα and IFNβ production by pDC was measured by intracellular
staining (A; n=3, B; n=1). (C) Spleen cellswere pre-incubatedwith (black bars) or without (white bars) 5 mg/mlmannan and then incubated for 23 h, with 530 HAU/ml inactivated
inﬂuenza virus or media (n=2). (D) Spleen cells were stimulated with 1.3 μg/ml H1 HA (n=7), H5 HA (n=6), gp120CN54 (n=2), SARS spike protein (n=1) or incubated in media
alone. (E) Fc-tagged H1 HA, H5 HA and gp120CN54 were incubated with GammaBind Plus Sepharose to deplete Fc tagged proteins. Volumes equivalent to 1 μg of H1 HA, H5 HA,
gp120CN54 and the corresponding preparations “depleted” of these Fc tagged proteins were separated by SDS-PAGE and protein was detected by silver staining (inset). In addition,
spleen cells were stimulated with 1.3 μg/ml H1 HA, 1.3 μg/ml H5 HA, 0.13 μg/ml gp120CN54 or equivalent volumes of the corresponding “depleted” preparations or in media alone for
23 h (n=2). (F) Spleen cells were pre-incubated with (black bars) or without (white bars) 5 mg/ml mannan and then stimulated with HA (n=2) or gp120CN54(VA) (n=1) or
incubated without further stimulation (media) for 23 h. In (C–F) IFN production was measured by bioassay.
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This assay measured IFN by the ability to inhibit Cocal virus
induced cytopathic effect on L929 cells [24]. Monolayers of L929 cells
in 96well tissue culture plates were incubated overnight at 37 °C with
2-fold serial dilutions of either IFNαA (from 250 U/ml) or samples in
100 μl serum free RPMI in duplicate wells. Subsequently cells werechallenged with 250–2150 pfu/ml Cocal virus (gift from W. James,
University of Oxford, UK) diluted in 100 μl serum free RPMI. As
controls, cells were incubated without IFN in 100 μl serum free RPMI
alone (cell control) or with Cocal virus only (virus control). After two
days the point of 50% cytopathic effect was determined microscop-
ically. The amount of IFN in the samples was estimated by comparison
with the standard curve from the IFNαA.
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As shown on each ﬁgure, n indicates the number of experiments
using cells from different mice. Where 3 or more replicate experi-
ments were conducted a 2-tailed t test or ANOVA with Bonferonni's
multiple comparison test, paired when appropriate, was performed
using GraphPad Prism 4.03 software. Means were considered
signiﬁcantly different when pb0.05. Error bars represent the standard
error of the mean.
3. Results
3.1. Lectin recognition of inﬂuenza glycoproteins leading to IFN induction
We have recently shown that murine splenic pDC from 129/SvEv
mice express a range of myeloid antigens, including the predomi-
nantly myeloid restricted receptors F4/80, CD36, Dectin-1, Dectin-2,
mannose receptor and CD200R, and the broadly expressed CD200
[12]. Here, we investigated whether these receptors were involved in
a key function of pDC, virally induced IFNα/β production. To
investigate a role for a lectin in sensing inﬂuenza virus, we used
mannan, a polymer of mannose, which blocks several lectins
including Dectin-2, mannose receptor and SIGNR1. Treatment of
spleen cells with mannan inhibited inﬂuenza virus stimulated IFNα
and IFNβ production by pDC (Fig. 1A). The inhibitory effect of mannan
on inactivated inﬂuenza virus-induced IFNα/β production by pDCwas
dose-dependent (Fig. 1B). In addition, treatment of spleen cells with
mannan had little effect on cell viability (data not shown).
Furthermore, mannan treatment reduced the production of functional
IFN (measured by bioassay) by spleen cells following inactivated
inﬂuenza virus stimulation (Fig. 1C). This led us to hypothesize that
inﬂuenza virus may induce IFNα/β production through the direct
recognition of mannosylated ligands on the inﬂuenza virus particle,
for example envelope glycoproteins, through a lectin.
In support of the hypothesis, a range of puriﬁed insect expressed
glycoproteins (H1 and H5 subtypes of inﬂuenza virus HA, HIV-1
gp120CN54 and SARS spike protein) were found to induce IFN
production by splenocytes (Fig. 1D). The inﬂuenza virus HA and
gp120CN54 used in Fig. 1D were Fc tagged, however the Fc tag was not
required for IFN induction as gp120 bearing an Fc tag mutated in
residues critical for Fc receptor binding (gp120CN54(VA)) (Fig. 1F) as
well as glycoproteins lacking an Fc tag altogether such polyhistidine
tagged gp120 (data not shown) and SARS spike (Fig. 1D) all induced
IFN production by spleen cells. To conﬁrm that the IFN induction was
speciﬁcally due to the HA or gp120 glycoproteins, and not a potential
contaminant within the samples, these Fc tagged proteins were
depleted from the preparations by incubation with protein G coated
sepharose beads (GammaBind Plus Sepharose). The mock PBS treated
and GammaBind Plus Sepharose treated “depleted” glycoprotein
samples were separated by SDS-PAGE and proteins visualized by
silver staining to demonstrate the effectiveness of the depletion by the
loss of a protein band at the expected molecular weight for the
glycoproteins (Fig. 1E, inset). Depletion of the HA or gp120CN54
abrogated IFN induction (Fig. 1E). Samples were treated with
polymyxin B to further conﬁrm that the IFN induction by HA was
not due to LPS. Polymyxin B treatment did not reduce IFN induction
(data not shown). These data show that a range of soluble
recombinant insect-expressed viral glycoproteins stimulated IFN
production by spleen cells.
To investigate whether a lectin could be involved in the
glycoprotein mediated IFN induction, spleen cells were treated with
mannan before and during stimulation with the glycoproteins.
Mannan also reduced IFN induction by H1 HA and gp120CN54(VA)
(Fig. 1F). Trypan blue staining of spleen cells treated with mannan
alone or together with the H1 HA and gp120CN54(VA) glycoproteins or
inactivated inﬂuenza virus conﬁrmed that mannan treatment did notaffect cell viability (Supplementary Fig. 1 and data not shown).
Dectin-2 is a lectin receptor expressed on pDC, which is mannan-
inhibitable. Given the increasing understanding of its roles in
signaling and DC activation [25], we investigated whether treatment
of splenocytes with the anti-Dectin-2 blocking mAb 11E4 had any
effect on inactivated inﬂuenza virus and CpG stimulated IFNα
production. However we observed that 11E4 treatment had no effect
on IFNα secretion (data not shown). In summary, these data suggest
the involvement of a lectin in viral glycoprotein sensing, leading to
IFNα/β production.
3.2. No involvement of Dectin-1 in IFNα/β induction
To assess the role of Dectin-1 in IFNα/β production by pDC, spleen
cells were treated with the blocking mAb 2A11 [18] before and during
stimulation with inactivated inﬂuenza virus. Treatment with this anti-
Dectin-1 mAb had no signiﬁcant effect on inactivated inﬂuenza virus
stimulated IFNα or IFNβ production by pDC compared to treatment
with an isotype control mAb or nomAb (Fig. 2A). In addition, blocking
with the Dectin-1 ligands laminarin or glucan phosphate did not affect
IFNα/β production by pDC following inactivated inﬂuenza virus
stimulation (Fig. 2B and C). These results suggest that Dectin-1 is not
required for inactivated inﬂuenza virus stimulated IFNα/β production
by pDC.
3.3. No involvement of CD36 and other scavenger receptors in IFNα/β
induction
pDC express functional scavenger receptor(s) including CD36
[12,26,27], therefore we tested whether a mAb against CD36 or more
general scavenger receptor ligands affected inactivated inﬂuenza
virus induced IFNα/β production by pDC. Spleen cells were treated
with the MF3 mAb against CD36, which has been recently found to
inhibit macrophage fusion by blocking CD36 [19], before and during
stimulation with inactivated inﬂuenza virus. Treatment with this anti-
CD36 mAb did not signiﬁcantly affect IFNα or IFNβ production by
inﬂuenza virus stimulated pDC compared to untreated cells (Fig. 3A).
Furthermore, incubation with fucoidan or maleylated BSA, which
block CD36 and other scavenger receptors, did not signiﬁcantly alter
IFNα or IFNβ production by pDC compared to controls (Fig. 3B).
Therefore, although pDC express CD36 we found no evidence that
CD36, nor scavenger receptors more generally, have a role in
inactivated inﬂuenza virus induced IFNα/β production by pDC.
3.4. F4/80 does not block IFNα/β induction
As several antibodies against highly expressed antigens on pDC
alter IFNα production [4,28] and pDC clearly express F4/80 [12], we
tested whether treatment of spleen cells with the mAb F4/80 affected
inﬂuenza virus stimulated IFNα/β production by pDC. The F4/80 mAb
has been shown to block IFNγ release from NK cells [17], however
treatment of spleen cells with F4/80 did not alter IFNα or IFNβ
production by pDC (Fig. 4). Therefore, despite clear expression on
pDC, no evidence was found that F4/80 plays a role in inﬂuenza virus
induced IFNα/β production by pDC.
3.5. Modulation of IFNα production by CD200
As pDC and other splenocytes express both CD200 and CD200R
[12], we testedwhether this immunomodulatory receptor–ligand pair
affected IFNα production. CD200 is known to have inhibitory effects
on myeloid cells, and consistent with this we found that CD200 KO
macrophages produced more IFNα than the C57BL/6J control
macrophages following polyI:C stimulation (Fig. 5A). To test the
effect of CD200 on pDC function, spleen cells were incubated with the
OX90 mAb against CD200, which blocks CD200 interaction with
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Fig. 2.No evidence for the involvement of Dectin-1 in inactivated inﬂuenza virus stimulated IFNα/β production by pDC. (A) Spleen cells were pre-incubatedwithmedia alone (white
bars), rat IgG2b isotype control mAb (gray bars) or 2A11 (anti-Dectin-1 mAb) (black bars) (antibodies at 100 μg/ml) and then incubated for 6 h with 530 HAU/ml inactivated
inﬂuenza virus or in media alone (n=2). (B) Spleen cells were pre-incubated for with 4 mg/ml laminarin (black bars) or media alone (none) and subsequently incubated for 6 h
with 200 HAU/ml inactivated inﬂuenza virus in media alone (n=1). (C) Spleen cells were pre-incubated with media alone (white bars) or with 100 μg/ml glucan phosphate (black
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mAb or no Ab and then stimulated with either of the MyD88-
dependent stimuli CpG ODN or inactivated inﬂuenza virus. OX90
treatment signiﬁcantly inhibited IFNα production by spleen cells at
23 h in response to CpG ODN stimulation (Fig. 5B). The same level of
blocking was observed with OX90 concentrations as low as 10 μg/ml
(data not shown). In addition, OX90 also slightly reduced IFNα
production by spleen cells in response to inactivated inﬂuenza virus,
however, the effect was not signiﬁcant by paired ANOVA (Fig. 5C).
Intriguingly, OX90 did not affect IFNα/β production by pDC following
9 or 12 h stimulation with CpG ODN (data not shown), suggesting the
effects of OX90 develop over time. OX90 was not toxic as treatment of
spleen cells for 23 h with 10 or 100 μg/ml OX90 or an isotype control
mAb, in the presence or absence of CpG ODN, had no effect on the
percentage of dead cells (data not shown). As a further control, a non-
blocking mAb against CD200R OX110, was tested. This mAb, binds to
CD200R, but does not disrupt its interaction with CD200 (unpublished
observation, N. Barclay). OX110 had no effect on IFNα production in
response to inﬂuenza virus or CpG ODN, compared to the isotype
control mAb (Fig. 5D), showing that a blocking Ab against the CD200-
CD200R interaction is required to inhibit the response. IFN production
by CpG ODN or inactivated inﬂuenza virus stimulated C57BL/6J or
CD200 KO splenocytes was also measured by bioassay, however due
to a large variation in the levels of IFN produced, this assay was not
powerful enough to enable meaningful interpretation. These data
suggest that CD200 promotes MyD88-dependent IFNα production, in
contrast to the known inhibitory effect of CD200 on myeloid cells andthe observation that CD200 deﬁcient macrophages produced higher
levels of IFNα in response to a MyD88-independent stimulus.
4. Discussion
In this study we tested whether several myeloid receptors found
on pDC have a functional role in viral recognition leading to IFNα/β
production. Although pDC expressed low levels of Dectin-1, no
evidence was found for a Dectin-1 function in induction of IFNα/β
in response to inactivated inﬂuenza virus. However, mannan, which
blocks receptors recognizing mannosylated ligands including the
mannose receptor, SIGNR1 and Dectin-2, inhibited IFNα/β production
by pDC following inﬂuenza virus stimulation, suggesting a function for
such lectins in viral recognition. Studies designed to identify a
function for a speciﬁc mannose binding receptor, utilizing mannose
receptor KO spleen cells or the blocking anti-SIGNR1 mAb ERTR9,
were inconclusive (data not shown) due to large ranges in IFN
production from C57BL/6J splenocytes and highly variable affects of
ERTR9. Others have shown that several monosaccharides, mannan
and anti-mannose receptor antiserum reduced IFNα production by
human peripheral blood mononuclear cells in response to herpes
simplex virus-1 [29]. Furthermore, mannan inhibited inﬂuenza virus
stimulated IFNα/β production by spleen cells [30]. Together these
studies implicate a mannose speciﬁc receptor and mannose receptor
in particular as being involved in IFNα induction in response to
several viruses either as an uptake receptor or a signaling pattern
recognition receptor.
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containing carbohydrates, we hypothesized that viral glycoproteins
were the stimulus for the mannan inhibitable component of IFN
induction. We found that highly mannosylated viral glycoproteins
produced in insect cells could stimulate IFN production by spleen cells
in a mannan-inhibited manner, suggesting a lectin could recognize
glycosylation of the viral proteins. Further evidence for viral
glycoproteins inducing IFN production is reviewed in [6]. Whether
this ability to induce interferon is a property of the viral glycoprotein
per se, or a result of protein expression in insect cells is currently
unclear. However, recognition of glycans synthesized in insect cells is
also relevant for the understanding of immune responses to insect
vector-borne viruses and vaccines which use recombinant proteins
expressed in insect cells.
Despite CD36 being highly expressed on pDCs we found no
evidence, through use of a blocking anti-CD36 mAb or scavenger
receptor ligands, that CD36 or another scavenger receptor wasmedia inactivated influenza virus
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may be interesting in future to test the requirement of CD36 in CpG
induced IFNα/β production by pDC as some scavenger receptors,
which are endocytic, can enable the uptake of CpG ODNwhich signals
through TLR9 in the endosomes of pDC to induce IFNα/β production
[31].
pDC also express F4/80 however the F4/80 mAb had no effect on
inactivated inﬂuenza virus induced IFNα/β production by pDC.
Because many antibodies against highly expressed antigens on pDC
have subsequently been found to modulate IFNα production by these
cells [4,28], F4/80 may be a useful tool to isolate or study pDC without
interfering with pDC function.
Previous work has shown that pDC expressed clearly detectable
CD200 and CD200R [12]. CD200 and CD200R are an immunomodu-
latory receptor–ligand pair which inhibit a range of myeloid cell
functions including cytokine secretion by macrophages. MyD88-
dependent TLRs recognize viruses and induce IFN in pDC, but IFNmedia inactivated influenza virus
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and IFNβ production by pDC was measured by intracellular staining (n=2).
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Fig. 5. CD200 differentially modulates IFNα production. (A) C57BL/6J and CD200 KO bone marrow-derived macrophages (2.5×106 cells/ml) were stimulated with 10 μg/ml poly I:C
for 24 h (n=7). Spleen cells were incubated with no Ab or 100 μg/ml rat IgG2a isotype control or OX90 (anti-CD200 blocking mAb) and then stimulated for 23 h with 1 μM CpG
(B) or 530 HAU/ml inactivated inﬂuenza virus (C) (n=3). (D) As a control, spleen cells were incubated with no Ab, rat IgG1 isotype control or OX110 (a non-blocking anti-CD200R
mAb) and then stimulated for 23 h with 530 HAU/ml inactivated inﬂuenza virus or 1 μM CpG (n=1). INFα production was measured by ELISA.
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dependent pathway (TLR-3). Because these two cell types use either
MyD88- or TRIF-dependent IFN production we compared them to
investigate the inﬂuence of CD200 on both MyD88 and TRIF mediated
signaling pathways. CD200 KOmacrophages producedmore IFNα than
the C57BL/6J macrophages, consistent with an inhibitory effect of
CD200 in these cells. Intriguingly, the OX90 blocking mAb against
CD200, signiﬁcantly inhibited CpGODN(TLR9- andMyD88-dependent)
IFNαproductionby splenocytes and reduced inactivated inﬂuenzavirus
(TLR7- and MyD88-dependent) induced IFNα, suggesting that CD200
normally enhances IFNα production via MyD88-dependent pathways
in these cells. It has been reported that treatment of pDC with soluble
CD200 can either induce IFNαproductionor enhanceCpG induced IFNα
production [32,33], supporting the hypothesis that CD200 has positive
regulatory functions. The effects of CD200 on pDC are likely to be
through its receptor CD200R as CD200 itself has no known signaling
capacity. It has been suggested that CD200 may also engage CD200R-
like molecules [34], however in extensive studies by Wright et al. and
Hatherley et al. no evidence was found that CD200 could interact with
CD200R2, CD200R3, CD200R4 or CD200RLe [35,36]. Intriguingly, there
are several viral homologues of CD200 which, in the limited assays
tested so far, behave similarly to the endogenous CD200. The fact that
several viruses possess CD200 homologues suggests that this molecule
is important in the virus lifecycle and may play a role in anti-viral
immunity.
In summary, we present evidence that CD200 may differentially
regulate IFNα induction pathways and have both negative and
positive regulatory functions. Our results suggest that CD200 inhibits
MyD88-idependent IFNα induction in macrophages, while in con-
trast, CD200 is a positive regulator of TLR9 (CpG ODN) and possibly of
TLR7 (inactivated inﬂuenza) MyD88-dependent IFNα inducing
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